Alzamend Neuro, Inc.ALZNNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-0.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -78.08% |
| 2024 | -13.31% |
| 2023 | 43.16% |
| 2022 | 296.72% |
| 2021 | 22.64% |
| 2020 | -71.11% |
| 2019 | 1044.08% |
| 2018 | 17.58% |
| 2017 | 0.00% |
| 2016 | 0.00% |